MDM2 and neoplasm: Among the 10 amplification-based oncogenes, we identified that six genes (MDM2, MYC, MYCL, MYCN, NKX2-1, and SKP2) were amplified and overexpressed in ≥10 tumor samples (Supplementary Fig. 3).